SynthesisDiabetes, obesity & metabolism2020

Sodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort study.

Anat Fisher et al.PubMed ↗Publisher ↗

No numbers read from the abstract.